Increased Use of Prophylactic Measures in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Open Access
- 25 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 66 (12), 4457-4466
- https://doi.org/10.1007/s10620-020-06796-0
Abstract
Background Nonsteroidal anti-inflammatory drugs (NSAIDs), pancreatic duct stenting, and intensive intravenous hydration have been proven to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Trial participation and guideline changes demanded an assessment of the clinical practice of post-ERCP pancreatitis prophylaxis. Aims The surveys aim to identify points of improvement to inform and educate ERCPists about current evidence-based practice. Methods Two anonymous surveys were conducted among Dutch gastroenterologists in 2013 (n = 408) and 2020 (n = 575) for longitudinal views and attitudes pertaining to post-ERCP pancreatitis prophylaxis and recognition of post-ERCP pancreatitis risk factors. Results In 2013 and 2020, respectively, 121 and 109 ERCPists responded. In the 2013 survey, 98% of them utilized NSAID prophylaxis and 62% pancreatic duct stent prophylaxis in specific cases. In the 2020 survey, the use of NSAIDs (100%), pancreatic duct stents (78%), and intensive intravenous hydration (33%) increased among ERCPists. NSAID prophylaxis was the preferred prophylactic measure for all risk factors in the 2020 survey, except for ampullectomy, pancreatic duct contrast injection, and pancreatic duct cannulation, for which NSAID prophylaxis and pancreatic duct stent combined was equally favored or preferred. Conclusion Rectal NSAIDs are the most applied post-ERCP pancreatitis prophylaxis in the Netherlands, followed by pancreatic duct stents and intensive intravenous hydration. Additionally, there is reason to believe that recent guideline updates and active research participation have led to increased prophylaxis implementation.Keywords
Funding Information
- ZonMw (837001506)
This publication has 35 references indexed in Scilit:
- The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placementGastrointestinal Endoscopy, 2015
- Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014Endoscopy, 2014
- Clinical usefulness and current problems of pancreatic duct stenting for preventing post-ERCP pancreatitisWorld Journal of Clinical Cases, 2014
- UK wide survey on the prevention of post-ERCP pancreatitisFrontline Gastroenterology, 2013
- Complications of ERCPGastrointestinal Endoscopy, 2012
- Individual and practice differences among physicians who perform ERCP at varying frequency: a national surveyGastrointestinal Endoscopy, 2011
- Prophylaxis of post-ERCP pancreatitis: a practice surveyGastrointestinal Endoscopy, 2010
- European Society of Gastrointestinal Endoscopy (ESGE)Guideline: Prophylaxis of post-ERCP pancreatitisEndoscopy, 2010
- Pancreatic Stents for Prevention of Post–Endoscopic Retrograde Cholangiopancreatography PancreatitisClinical Gastroenterology and Hepatology, 2007
- A survey of physician practices on prophylactic pancreatic stentsGastrointestinal Endoscopy, 2006